PALBOCICLIB for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 1,996 adverse event reports in the FDA FAERS database where PALBOCICLIB was used for Neoplasm malignant.

Most Reported Side Effects for PALBOCICLIB

Side Effect	Reports	%	Deaths	Hosp.
Fatigue	15,190	16.7%	522	1,889
White blood cell count decreased	11,273	12.4%	420	1,505
Neoplasm progression	10,885	12.0%	1,499	1,400
Death	8,410	9.2%	8,384	556
Nausea	8,189	9.0%	346	1,395
Neutropenia	6,423	7.1%	313	759
Alopecia	6,201	6.8%	137	619
Diarrhoea	5,635	6.2%	187	983
Asthenia	3,660	4.0%	320	920
Off label use	3,405	3.7%	353	451
Decreased appetite	3,400	3.7%	238	757
Pain	3,384	3.7%	179	698
Malaise	3,294	3.6%	199	710
Dyspnoea	3,178	3.5%	304	1,116
Vomiting	3,060	3.4%	236	929